In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major ...
UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...
For the first time, scientists have used innovative tech to demonstrate that a healthy microbiome needs a consistent flow of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback